NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Viral Genomics


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
ABL is Pleased to Announce the TherapyEdge ViroScore Suite Platform is Now Available in Brazil
2009 NOV 23 ... ViroScore Suite™ and other online services primarily in the field of HIV/AIDS and viral hepatitis. Through the agreement, Centro de Genomas will provide the ... tools to support their clinical routine but also their research from therapeutics to genomics," said Dr Ricardo Sobhie Diaz, Medical Director of Centro de Genomas. More ...
Subject: ABL GROUP
Price: $3.00
*
Luminex Corporation Launches New xTAGRVP.com Respiratory Virus Testing and Information Website
2009 NOV 17 ... website offers the latest information on Luminex's xTAG® RVP Respiratory Viral Panel (RVP), a comprehensive multiplexed test for the detection of multiple viral ... drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics research markets. The Company's xMAP Technology is sold worldwide and is ...
Subject: Virology
Price: $3.00
*
New cancer gene therapy research reported from Arizona State University
2009 NOV 23 ... of the virus as well as poor transduction efficiency, since the protein used for viral entry (CAR) serves physiological functions in adhesion and is frequently decreased among ... Bladder Cancer, Bladder Carcinoma, Cancer Gene Therapy, DNA, Drug Development, Genetics, Genomics, Molecular Pharmacology, Molecular Therapies, Oncology, Pharmaceuticals, Physiology, ...
Subject: Cancer Gene Therapy
Price: $3.00
*
New research on virology from University of Alabama summarized
2009 NOV 23 ... virus thymidine kinase (HSV-tk) and monomeric red fluorescent protein 1 (mRFP1) into the viral capsid and its genomic stability were verified by molecular analyses. Replication and ... States, Adenoviridae, Biotechnology, Drug Development, Enzymes, Gene Therapy, Genetics, Genomics, Gynecology, Herpes Simplex, Herpes Simplex Virus, Herpes Virus, Herpesvirus, Kinase, ...
Subject: Virology
Price: $3.00
*
No-entry zones for AIDS virus
2009 NOV 29 ... block the work of an enzyme called integrase, which is responsible for integrating the viral DNA into the DNA of the infected cell.This enzyme is currently in the focus ... Acquired Immunodeficiency Syndrome, Biotechnology, Cancer, DNA, Gene Therapy, Genetics, Genomics, HIV, Human Immunodeficiency Virus, Oncology, Protease Inhibitor, Treatment, Viral, ...
Subject: Helmholtz Association of German Research Centres
Price: $3.00
*
Research from S. Cotton and co-authors in the area of virology published
2009 NOV 17 ... express a fluorescent protein (green fluorescent protein [GFP] or mCherry) fused to the viral 6K2 protein known to induce vesicle formation. Cytoplasmic fluorescent discrete protein ... St. NW, Washington, DC 20036-2904, USA. Keywords: Canada, Laval, Genetics, Genomics, Virology. This article was prepared by Life Science Weekly editors from ...
Subject: Virology
Price: $3.00
*
Researchers' work from Children's Hospital focuses on life sciences
2009 NOV 23 ... MNP represents a promising approach with a potential to extend the applicability of the viral gene therapeutic strategies." Chorny and colleagues published their study ... Molecular Therapies, Therapy, Treatment, Biotechnology, Gene Therapy, Genetics, Genomics, Pharmaceuticals, Children's Hospital. This article was prepared by ...
Subject: Life Sciences
Price: $3.00
*
Sigma-Aldrich Enters Distribution Agreement With Stemgent, Inc. to Offer Lentivirus-Based Gene Delivery Products for Regenerative Medicine and Stem Cell Research
2009 NOV 23 ... reprogramming technologies offered under the terms of the agreement involve proprietary viral vectors from Stemgent, lentivirus technology from Sigma-Aldrich and Dox Inducible ... Biotechnology, Biotechnology Business, Biotechnology Company, Gene Therapy, Genetics, Genomics, Marketing and Licensing Agreements, Regenerative Medicine, Stem Cell Research, Tissue ...
Subject: Regenerative Medicine
Price: $3.00
*
Studies from Harvard University in the area of virology published
2009 NOV 16 ... screening protocol to allow identification of host factors involved in the complete viral lifecycle. The candidate genes found included known or previously identified factors, ... Boston, Bioengineering, Biomedical Engineering, Biomedicine, Biotechnology, Functional Genomics, Gastroenterology, Gene Therapy, Genetics, Genomics, HCV, Hepatitis C Virus, Hepatology, ...
Subject: Virology
Price: $3.00
*
Studies from M. Chevillotte and co-researchers update current data on cytomegalovirus
2009 NOV 16 ... cytomegalovirus (HCMV) is the phenotypic characterization of mutations identified in the viral protein kinase gene UL97 and the viral DNA polymerase gene UL54 regarding their ... Cytomegalovirus, DNA, Drug Development, Drug Therapy, Enzymes, Gene Therapy, Genetics, Genomics, Kinase, Polymerase, Treatment, Viral, Virology, Virus. This article was ...
Subject: Cytomegalovirus
Price: $3.00
*
Studies from National Institute of Allergy and Infectious Diseases describe new findings in vaccinia
2009 NOV 16 ... from the United States, "Poxviruses encode many if not all of the proteins required for viral genome replication in the cytoplasm of the host cell. In this context, we investigated ... Keywords: United States, Bethesda, Allergies, Allergy Medicine, DNA, Enzymes, Genetics, Genomics, Infectious Diseases, Nuclease, Vaccinia, Vaccinia Virus, Virology, National Institute ...
Subject: Vaccinia
Price: $3.00
*
Studies from University of Arkansas provide new data on virology
2009 NOV 16 ... "Penn-98-1 behaved like MHV-2, thus establishing a role for the spike protein in viral growth. The inverse correlation between viral fusogenicity and growth was further ... Little Rock, Astrocytoma, Coronaviridae, Coronavirus, Gastroenterology, Genetics, Genomics, Hepatitis, Infectious Disease, Virology, University of Arkansas. This ...
Subject: Virology
Price: $3.00
*
Studies from University of Hong Kong, Department of Medicine describe new findings in life sciences
2009 NOV 16 ... A report, 'Non-viral Smad7 gene delivery and attenuation of postoperative peritoneal adhesion in an ... Keywords: Hong Kong, Life Sciences, Biotechnology, Gene Therapy, Genetics, Genomics, Experimental Model, Treatment, Gastroenterology, Surgery. This article was ...
Subject: Life Sciences
Price: $3.00
*
Studies in the area of virology reported from J.H. Huang and co-researchers
2009 NOV 23 ... ischemic limb or heart. In this study, we constructed a human Ang-1-expressing Sendai viral vector (SeVhAng-1) and injected it into the ischemic limb of rats," scientists in ... City:Sapporo, Country:Japan, Angiogenesis, Biotechnology, Gene Therapy, Genetics, Genomics, Ischemia, Oncology, Sendai Virus, Treatment, Tumor Vascularization, Viral, Virology. ...
Subject: Virology
Price: $3.00
*
Tabriz University of Medical Sciences, Faculty of Pharmacy publishes research in cancer gene therapy
2009 NOV 16 ... therapy using gelatin is lacking in both efficiency and specificity in comparison with viral vectors, whereas complexes of therapeutic DNA with modified gelatin possibly offer a ... Keywords: Iran, Biotechnology, Cancer Gene Therapy, DNA, Drug Development, Genetics, Genomics, Oncology, Pharmaceuticals, Treatment. This article was prepared by Biotech ...
Subject: Cancer Gene Therapy
View Free
Daily News
Article
TGen seeks emergency FDA approval of new swine flu test
2009 NOV 16 ... to oseltamivir (sold under the brand name Tamiflu®; Roche), the primary anti-viral drug on the market to treat H1N1. As with other influenza strains, H1N1 flu ... The Phoenix-based non-profit Translational Genomics Research Institute (TGen) announced that, along with a business collaborator, it will ...
Subject: The Translational Genomics Research Institute
Price: $3.00
*
Valeant Pharmaceuticals Highlights Taribavirin Phase IIb End of Study Data Presentation at American Association for the Study of Liver Disease (AASLD) Annual Meeting
2009 NOV 16 ... with a 24-week post-treatment follow-up period. Consistent with previous reports, the viral response data continued to show comparable reductions in viral load for weight-based ... Chronic Hepatitis C, Clinical Trial Research, Drugs, Gastroenterology, Genetics, Genomics, Genotyping, Hepatology, Infectious Disease, Interferon, Liver Disease, Pharmaceutical ...
Subject: Chronic Hepatitis C Virus
Price: $3.00
*
Worlds first engineered T cell receptor trial opens with new cellular therapy for HIV
2009 NOV 16 ... Regulatory Actions, Tissue Engineering, Treatment, U.S. Food and Drug Administration, Viral, Viral Inhibition, Viral Therapy, Virology. This article was prepared by ... Cancer Vaccines, Clinical Trial Research, Drug Development, FDA, Gene Therapy, Genetics, Genomics, HAART, HIV, Human Immunodeficiency Virus, Immunization, Immunotherapy, Infectious ...
Subject: Virology
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login